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Abstract Members of the HERC (domain homologous to E6
associated protein carboxy-terminus and RCC1 domain protein)
family may function both as guanine nucleotide exchange factors
and E3 ubiquitin ligases. Here we identify an unstudied member,
HERC3. This protein was recognized by specific antibodies in
different cell types. HERC3 was located in the cytosol and in
vesicular-like structures containing L-COP, ARF and Rab5
proteins. Involvement of HERC3 in the ubiquitin system was
suggested by its ability to interact with ubiquitin. The conserved
cysteine in HECT proteins was not essential for this non-covalent
binding. Moreover, HERC3 was a substrate of ubiquitination
being degraded by the proteasome. These observations indicate a
fine regulation of HERC3 and suggest a role in vesicular traffic
and ubiquitin-dependent processes. ß 2001 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
Proteins that have a domain homologous to E6 associated
protein (E6-AP) carboxy-terminus (HECT domain) and one
or more regions with homology to the regulator of chromo-
some condensation (RCC1) have recently received the
HGNC-approved designation of HERC for HECT and
RCC1 domains [1]. RCC1 is the only guanine nucleotide ex-
change factor (GEF) found for the small GTPase Ran [2],
which is involved in nucleocytoplasmic transport and the for-
mation of the mitotic spindle [3]. Ran, like the other small
GTPases of the Ras superfamily, switches between two states:
an inactive GDP-bound form, and an active GTP-bound
form. Through this mechanism small GTPases regulate cell
proliferation, cytoskeletal morphology and intracellular trans-
port [4^6]. GEFs act as positive modulators by promoting the
exchange of GDP for GTP. Proteins containing HECT do-
mains constitute a subclass of E3 ubiquitin ligases [7]. These
ligases participate in the ubiquitin pathway which is respon-
sible for the attachment of ubiquitin moieties to substrate
proteins, a modi¢cation that serves as a signal both for pro-
teasome-mediated proteolysis and for the internalization of
membrane proteins. The transference of ubiquitin to the sub-
strate involves a thioester bond between ubiquitin and a spe-
ci¢c cysteine residue within E3 molecules, while the attach-
ment of ubiquitin to target proteins occurs through isopeptide
bonds between ubiquitin and lysine positions in the substrates
[8,9]. The presence of HECT and RCC1-like domains (RLDs)
in HERC proteins suggests that this protein family may func-
tion both as E3 ubiquitin ligases and as GEFs.
The human HERC family has four members. HERC1/p532
gene was isolated during the course of a gene transfer assay to
identify novel oncogenes from human tumor DNA. Biochem-
ical data on HERC1 suggest that it is involved in intracellular
tra⁄cking [10,11]. HERC2 was identi¢ed as the gene respon-
sible for the rjs (runty, jerky and sterile) or jdf-2 (juvenile
development and fertility-2) phenotype in mice [1,12].
HERC2 protein is closely related to HERC1 and HERC2
mutants present secretory defects, which also suggests a func-
tion in vesicular tra⁄cking [1,12]. HERC4 has recently been
isolated from a two-hybrid screening using cyclin E and p21
as bait [13]. This protein has received the name of Ceb-1, for
cyclin E binding protein-1, and it also interacts with cyclin A,
B1 and D1. Expression of HERC4 is limited to reproductive
tissues where it might have a role in the cell cycle as suggested
by its association with cyclins. Finally, HERC3/D25215 gene
was identi¢ed during a random search for human cDNAs
larger than 2 kb [14]. While HERC1 and HERC2 are highly
related proteins, the putative HERC3 resembles HERC4 and
emerges as the HERC4 homologue in non-reproductive tis-
sues [13,15]. HERC3 protein has not been characterized but
the predicted protein contains a single amino-terminal RLD
and a carboxy-terminal HECT domain. Here we report the
identi¢cation of the HERC3 protein. HERC3 shows a sub-
cellular distribution between cytosol and membranes similar
to that found for other proteins involved in vesicular tra⁄c.
We also show that although HERC3 does not function as a
Ran-GEF, it interacts with ubiquitin and is targeted for ubiq-
uitination. Taken together, these results suggest a role for
HERC3 in ubiquitin-dependent intracellular processes.
2. Materials and methods
2.1. Plasmids and baculovirus
2.1.1. Mammalian expression plasmids. Human D25215/HERC3
cDNA was kindly provided by Dr. N. Nomura [14]. An EcoRI-BglII
polymerase chain reaction (PCR) fragment corresponding to nucleo-
tides 167^1263 of D25215/HERC3 cDNA was fused to nucleotides
1264^3370 (BglII-StuI) digested from D25215 cDNA and subcloned
in frame into EcoRI-EcoRV sites of pcDNA3.1 HisC (Invitrogen) to
generate 6xHis-HERC3 (pCC36). C1018A 6xHis-HERC3 mutant
(pCC43) was obtained by site-directed mutagenesis (Stratagene) using
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oligonucleotides 5P-CGGTGGCCCACACAGCTTACAACCTTCT-
TG-3P and 5P-CAAGAAGGTTGTAAGCTGTGTGGGCCACCG-
3P, which contain silent mutations for a diagnostic AluI site in addi-
tion to the cysteine to alanine mutation. Myc-tagged HERC4 RLD
(residues 1^323) cDNA cloned into pCS2MT was kindly provided
by Dr. M. Ohtsubo [13].
2.1.2. Glutathione-S-transferase (GST)-fusion proteins. The ¢rst
half of RLD (residues 1^199), the full RLD (residues 1^392) and
the HECT domain (residues 848^1050) were ampli¢ed by PCR from
D25215/HERC3 cDNA with speci¢c oligonucleotides and subcloned
into EcoRI and XhoI sites of pGEX-4T-1 (Pharmacia) to obtain
pCC1, pCC2 and pCC3 plasmids, respectively. GST-HERC3
(pCC38) was obtained by subcloning an EcoRI-XhoI insert from
pCC36 into pGEX-4T-1. Ubiquitin was ampli¢ed by PCR with spe-
ci¢c oligonucleotides from HeLa cDNA library (Stratagene) and sub-
cloned into pGEX-2TK (Pharmacia) to generate GST-ubiquitin
(pJLR86). Human RCC1 cDNA from pJLR8 [10] was subcloned
into BamHI/NotI pGEX-5X-1 (Pharmacia) to generate GST-RCC1
(pJLR135).
2.1.3. Baculovirus. ARF6-6xHis was obtained by PCR ampli¢ca-
tion with speci¢c oligonucleotides from human ARF6 cDNA (kindly
provided by Dr. J. Donaldson) and subcloned into pFastBac1
(pJLR134). ARF6 baculovirus was generated with the Bac-to-Bac
system following the manufacturer’s instructions (Gibco BRL).
RCC1, HERC1 RLD1, HERC1 RLD2, Ran, Rab3A, Rab5, Rab8
and ARF1 baculoviruses are described elsewhere [10]. All DNA am-
pli¢ed by PCR was sequenced to con¢rm that no errors were intro-
duced by the polymerase.
2.2. Protein puri¢cation and guanine nucleotide exchange assays
2.2.1. Protein puri¢cation. RCC1, HERC1 RLD1, HERC1
RLD2, Ran, Ras, Rab3A, Rab5, Rab8, ARF1 and ARF6 were ex-
pressed in Sf9 cells and puri¢ed as described [10]. GST-Rac and GST-
RhoA were kindly provided by Dr. X.R. Bustelo. Proteins encoded by
GST-RLD (residues 1^199; pCC1) and GST-HECT (pCC3) formed
inclusion bodies and were used to generate antibodies. Soluble GST-
RCC1 (pJLR135), GST-HERC3 (pCC38) and GST-RLD (residues 1^
392; pCC2) fusion proteins were expressed in BL21 bacteria, puri¢ed
according to standard procedures with glutathione-Sepharose (Amer-
sham Pharmacia Biotech AB) and used for nucleotide exchange as-
says. GST and GST-ubiquitin were also puri¢ed by standard gluta-
thione-Sepharose a⁄nity.
2.2.2. Guanine nucleotide exchange assays. These experiments were
performed essentially as described [10].
2.3. Antibodies
Puri¢ed proteins GST-RLD (residues 1^199) or GST-HECT (resi-
dues 848^1050) were subcutaneously injected into rabbits to raise anti-
HERC3 rabbit polyclonal antibodies CC1, CC2 and CC3, CC4, re-
spectively. For Western blot analysis, either whole antisera or immu-
noglobulins separated from whole antisera by standard methods [16]
were used at 1/1000 dilution. For immuno£uorescent staining, anti-
bodies were immunoa⁄nity puri¢ed and used at 1/50 dilution. Mouse
monoclonal antibodies (mAbs) against ARF proteins (1D9), anti-
Rab5, anti-L-COP (M3A5), and anti-transferrin receptor were kindly
provided by R. Kahn, J. Blasi, T.E. Kreis, and M. Camps, respec-
tively. Anti-Golgi protein GMPt1 (18B11) and anti-LIMPII (38C7)
were a kind gift from I.V. Sandoval. Monoclonal antibodies anti-
Hsp70 and anti-c-myc were from Oncogene Science. Anti-K-tubulin
(Ab-1) and anti-M2-pyruvate kinase (clone DF4) were from Calbio-
chem and ScheBo.Tech, respectively. Swine anti-rabbit antibodies
conjugated to Texas Red and sheep anti-mouse antibodies labeled
with £uorescein were from DAKO.
2.4. Cell culture and transfection
CCD45-SK, MCF-7, HeLa, NRK and COS-1 cells were maintained
in Dulbecco’s modi¢ed Eagle’s medium supplemented with 10% fetal
calf serum and antibiotics. Peripheral blood lymphocytes (PBLs) were
isolated from blood from healthy human donors by centrifugation on
a Ficoll gradient. For comparison of HERC3 expression in di¡erent
cell types, exponentially growing cells were washed twice in cold phos-
phate-bu¡ered saline (PBS) and lysed in bu¡er 50 mM Tris^HCl pH
8.0, 150 mM NaCl, 1% Triton X-100, 1 mM ethylenediaminetetra-
acetic acid (EDTA), 1 Wg/ml aprotinin, 1 Wg/ml pepstatin A, 1 Wg/ml
leupeptin, 100 Wg/ml benzamidine, 1 mM phenylmethylsulphonyl £u-
oride (PMSF), 1 mM NaF, 100 WM orthovanadate; supernatants
were recovered after 10 min centrifugation at 13 000Ug. Transfection
of COS-1 cells was performed using the DEAE-dextran method with
6^8 Wg DNA per 100 mm plate. After two washes in cold phosphate-
bu¡ered saline (PBS) cell extracts were prepared with 10 mM Tris^
HCl pH 7.5, 150 mM NaCl, 0.2% Triton X-100 supplemented with
1 mM EDTA, 10 Wg/ml aprotinin, 1 Wg/ml pepstatin A, 5 Wg/ml
leupeptin, 100 Wg/ml benzamidine, 0.5 mM PMSF, 1 mM NaF, 100
WM orthovanadate. If treatment with N-acetyl-leucinyl-leucinyl-N-
norleucinal (LLnL) was required, the day after transfection cells
were split into two 60 mm plates. After allowing 8^10 h for cell
adhesion, cells were treated overnight with 50 WM LLnL (Sigma) or
with the same volume of dimethyl sulfoxide (DMSO) in fresh me-
dium. Cell extracts were prepared after washing cells twice in cold
PBS by boiling cells for 15 min with 25 mM Tris^HCl, pH 7.5,
1.5% sodium dodecyl sulphate (SDS). Proteins were determined by
the BCA Protein Assay (Pierce).
2.5. Cell fractionation
Exponentially growing COS-1 cells were rinsed twice with cold PBS
and scraped in bu¡er containing 10 mM Tris^HCl pH 7.5, 10 mM
KCl, 1.5 mM MgCl2, 250 mM sucrose, 1 mM EDTA, 10 Wg/ml
aprotinin, 10 Wg/ml leupeptin, 5 Wg/ml pepstatin A, 100 Wg/ml benza-
midine, 0.5 mM PMSF, 1 mM NaF, 100 WM orthovanadate. Cells
were disrupted by successive passage through a 27G needle. Cell
breakage and nucleus integrity were monitored by trypan blue stain-
ing. Nuclei were harvested by 10 min centrifugation at 1000Ug fol-
lowed by resuspension and recentrifugation to eliminate traces of
cytosol. The postnuclear fraction was subsequently centrifugated at
100 000Ug for 1 h. After recovering the supernatant (cytosol), the
pellet (membranes) was rinsed and recentrifugated. All steps were
done in the cold. Final fractions were adjusted to the same ¢nal
volume before preparing samples for Western blot with sample bu¡er
(62.5 mM Tris^HCl pH 6.8, 2% SDS, 10% glycerol, 100 mM dithio-
threitol (DTT)).
2.6. Immuno£uorescent staining
NRK cells were seeded on coverslips. The following day, cells were
¢xed in freshly prepared solution (3% paraformaldehyde, 60 mM
sucrose, 0.1 M sodium phosphate pH 7.2) for 30 min at room temper-
ature. After three washes in PBS for 5 min, cells were washed with
PBS 20 mM glycine for 5 min, permeabilized in PBS 20 mM glycine
0.1% saponin for 10 min at room temperature, washed with PBS 20
mM glycine for 5 min and blocked with PBS 20 mM glycine 1%
bovine serum albumin (BSA) for 10 min at room temperature. Incu-
bation with primary antibodies was done in blocking solution for 1 h
at 37‡C. After washing in PBS glycine for 5 min cells were incubated
with secondary antibodies in blocking solution for 45 min at 37‡C.
Finally, cells were washed for 10 min in PBS and mounted with
mowiol (Calbiochem) and analyzed by confocal microscopy.
2.7. Ubiquitin binding assays
2.7.1. Experiments in the rabbit reticulocyte system. Radiolabeled
wild-type (pCC36) and mutant (pCC43) HERC3 proteins were pro-
duced using T7 Quick coupled TNT kit (Promega) as indicated by the
manufacturer. After protein synthesis, aliquots (20 Wl) were removed
and incubated for 15^30 min with or without 6.5 Wg GST-ubiquitin at
room temperature. Reactions were stopped at 100‡C for 10 min with
sample bu¡er, and proteins were analyzed by SDS^PAGE. After elec-
trophoresis gels were ¢xed, dried and autoradiographed. For pull-
down assays, after the transcription/translation reaction identical ali-
quots were incubated with 5^10 Wg of either GST beads or GST-
ubiquitin beads for 15^20 min at room temperature. After binding,
the reaction was stopped at 4‡C and washed six times with 1 ml of
cold bu¡er (10 mM Tris^HCl pH 7.5, 150 mM NaCl, 0.2% Triton X-
100). Beads were recovered in sample bu¡er and proteins analyzed as
above. After electrophoresis gels were stained with Coomassie blue,
dried and autoradiographed. For competition assays, 5 Wg of GST,
5 Wg of GST-ubiquitin or 5 Wg of GST-ubiquitin plus 10 Wg of free
ubiquitin were used.
2.7.2. Experiments in bacteria. BL21 cells harboring a control
plasmid or GST-HERC3 encoding plasmid (pCC38) were grown to
same absorbance (V= 600 nm) and induced with IPTG for 2 h. Brie£y,
cells were sonicated in bu¡er 10 mM Tris^HCl pH 7.5, 0.2 mM DTT
and then Triton X-100 was added at a ¢nal concentration of 0.2%.
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After centrifugation the cleared lysates were incubated with either
GST matrix or GST-ubiquitin matrix for 100 min at 4‡C. After wash-
ing four times with cold bu¡er (10 mM Tris^HCl pH 7.5, 150 mM
NaCl, 0.2% Triton X-100) equal aliquots of the a⁄nity matrices were
removed, eluted with sample bu¡er and analyzed by Western blot.
Control GST and GST-ubiquitin matrices were obtained by cross-
linking 1.5 mg of proteins to a mixture of 0.5 ml A⁄gel 10 and 0.5
ml A⁄gel 15 (Bio-Rad) following manufacturer’s instructions and
were extensively washed before use.
3. Results
3.1. Identi¢cation of HERC3 protein
We generated two di¡erent classes of sera: CC1 and CC2
against HERC3 RLD, and CC3 and CC4 against the HECT
domain (Fig. 1A). Initially these antibodies were tested by
Western blot against the puri¢ed antigens to compare their
sensitivity. As expected, the four antisera detected the puri¢ed
antigens, as shown in Fig. 1A for CC1 and CC3 antibodies.
Similar results were obtained with CC2 and CC4 antisera
(data not shown). We found the highest sensitivity for CC1
antiserum. A 1:1000 dilution of CC1 serum detected 0.1 ng of
GST-RLD fusion protein (Fig. 1A). Next, we tested the abil-
ity of these antibodies to detect endogenous HERC3 protein.
Extracts from COS-1 cells were analyzed by SDS^PAGE and
Western blot using CC1 and CC3 antibodies. A major band
with a molecular mass of approximately 117 kDa, the size
expected for the protein encoded by the human HERC3/
D25215 cDNA, was observed (Fig. 1B, vector lane of upper
panels). To con¢rm this band as the HERC3 protein, COS-1
cells were transfected with the full-length HERC3 cDNA.
Overexpression of HERC3 caused an increase in immunore-
activity of the 117 kDa band (Fig. 1B, HERC3 lane of upper
panels). Immunodetection of K-tubulin was used as control
for loading. To rule out that CC1 antibodies recognized
HERC4/Ceb-1 protein which has a similar size [13], COS-1
cells were also transfected with the myc-tagged RLD of
HERC4. CC1 antibodies did not show cross-reaction with
the HERC4 RLD (Fig. 1B, HERC4 RLD lane of upper left
Fig. 1. Anti-HERC3 antibodies and HERC3 protein. A, upper panel: Schematic representation of HERC3 protein indicating the position of
RLD and HECT domains. GST-fusion proteins used to generate anti-HERC3 antibodies are also depicted. Scale bar indicates 100 amino acidic
residues. Lower panel: Testing anti-HERC3 antibodies. Antisera CC1 (left panel) and CC3 (right panel) at 1:1000 dilution were tested against
increasing amounts of their respective antigens. B: Immunoblot of cellular lysates. Protein extracts (70 Wg) for COS-1 cells transfected with 6 Wg
of pcDNA3.1HisC (vector), expression plasmid pCC36 (HERC3) or expression plasmid encoding myc-tagged HERC4 RLD (residues 1^323)
were resolved by 8% PAGE/SDS and immunoblotted with anti-HERC3 antibodies CC1 and CC3 (top panel), anti-K-tubulin antibody (middle
panel) or anti-c-myc antibody (bottom panel). C: CC1 antibody speci¢city toward RLD-containing proteins. W150 ng of puri¢ed HERC3
RLD, RCC1, HERC1 RLD1 and HERC1 RLD2 were resolved by 10% PAGE/SDS and either stained with Coomassie (left panel) or immuno-
blotted with CC1 antibodies (right panel). D: HERC3 expression in di¡erent cell types. Protein extracts (100 Wg) from human (PBL, CCD45-
SK, MCF-7 and HeLa), monkey (COS-1) and rat (NRK) cells were resolved by 6% PAGE/SDS and immunoblotted with CC1 antibody. Mo-
lecular mass markers are indicated in kDa. Arrowheads show the positions of indicated proteins. IB, immunoblot.
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panel). We have also analyzed the speci¢city of CC1 antibod-
ies against RCC1 and the RCC1-like domains of HERC1
(RLD1 and RLD2). Puri¢ed RCC1, RLD1, RLD2 and the
GST-HERC3 RLD (residues 1^392) (see Coomassie staining,
Fig. 1C) were analyzed by Western blot. As shown in Fig. 1C,
CC1 antibodies speci¢cally recognized the HERC3 RLD. To
analyze the expression of endogenous HERC3 protein in oth-
er cell types, we performed Western blot analysis using lysates
from human cells (PBLs, peripheral blood lymphocytes;
CCD45-SK, skin ¢broblasts; MCF-7 and HeLa, epithelial
carcinoma cells), monkey cells (COS-1, kidney ¢broblasts)
and rat cells (NRK, kidney ¢broblasts). A major band of
approximately 117 kDa was immunodetected in all the cell
types using CC1 antibodies (Fig. 1D). Less intense lower im-
munoreactive bands were also detected in some cases.
Whether they represent degradation products or isoforms re-
mains to be determined. Similar results were obtained using
CC3 antibodies (data not shown). Altogether these results
show that HERC3 antisera are sensitive and speci¢c to detect
HERC3 protein and that HERC3 is present in di¡erent cell
types and species.
3.2. Subcellular location of HERC3 and GEF activity
To localize HERC3 protein, we analyzed its subcellular
distribution in COS-1 cells. Cells were fractionated into three
fractions: nuclei, membranes and cytosol. Transferrin recep-
tor was used as a marker for membranes; K-tubulin for cyto-
sol; Hsp70 as a protein ubiquitously distributed. Western blot
analysis with anti-HERC3 antibodies revealed the presence of
HERC3 mainly in the cytosol (Fig. 2A); a small amount was
also detected in the membrane fraction after overexposition
(data not shown). Similar results were obtained in NRK cells
and MCF-7 cells (data not shown). The localization of
HERC3 was also studied by confocal microscopy using im-
munopuri¢ed CC1 antibodies. A punctate staining of endog-
enous HERC3 was observed throughout the cytosol of NRK
Fig. 2. HERC3 intracellular location and GEF activity. A: Cellular fractionation. COS-1 cells were disrupted and separated into three frac-
tions: nuclei (N), cellular membranes (Mb) and cytosol (C). Protein equivalents of these fractions were resolved by 6% PAGE/SDS and immu-
noblotted against HERC3, transferrin receptor (TfR), Hsp70 and K-tubulin. The positions of these proteins are indicated by arrowheads. B:
Double immuno£uorescence analysis with anti-HERC3 and anti-Golgi antibodies. NRK cells were grown on coverslips, ¢xed, stained with im-
munopuri¢ed rabbit antibodies against HERC3 (red) and mAb antibody against Golgi protein GMPt1 (green) and analyzed by confocal mi-
croscopy. Colocalization is shown in yellow. Scale bar represents 10 WM. C: Immuno£uorescence analysis with anti-HERC3 antibodies and ly-
sosomal and vesicular markers. NRK cells processed as in B were stained with anti-HERC3 immunopuri¢ed antibodies (middle panel, red) and
mAbs against either L-COP, ARF, Rab5 or LIMPII protein (left panel, green). Colocalization analysis was performed by confocal microscopy
and colocalization (right panel, merge) is indicated in yellow. Scale bar represents 10 Wm. D: Exchange activity on Ran. Ran (1.5 Wg) was
loaded with [3H]GDP and incubated for the indicated periods of time with bu¡er (open circles) or the following fusion proteins: GST-RCC1
(solid circles), GST-HERC3 (solid triangles) or GST-HERC3 RLD (residues 1^392) (solid squares). At each time point, aliquots from each con-
dition were taken in duplicate and the amount of [3H]GDP-bound Ran quanti¢ed by ¢lter immobilization assay. E: Exchange activity on
Rab3A, Rab5, Rab8, ARF1, ARF6, Ras, Rac and RhoA. GTPases were loaded with [3H]GDP and incubated with albumin (open bars) or
GST-HERC3 protein (dashed bars). After 10 min, [3H]GDP-bound GTPases were quanti¢ed as in A. Results are expressed as percentage of
[3H]GDP bound to the GTPases just before the addition of the factors. Each value is the mean of two determinations.
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cells (Fig. 2B). The same result was observed in COS-1 and
CCD45-SK cells (data not shown). Although HERC3 is
mainly a cytosolic protein (Fig. 2A) a minor fraction of
HERC3 could be associated with intracellular membranes.
To de¢ne this distribution, we have analyzed its colocalization
with di¡erent membrane markers. Double staining with anti-
bodies against L-COP and HERC3 revealed a degree of colo-
calization, as con¢rmed when the images were overlaid (Fig.
2C). Similar results were obtained when NRK cells were cos-
tained with antibodies against ARF or Rab5 proteins,
GTPases involved in vesicular tra⁄c, and HERC3 (Fig. 2C).
The greatest colocalization was found with Rab5. In contrast,
HERC3 did not colocalize with the trans-Golgi membrane
protein GMPt1 or the lysosomal protein LIMP-II (Fig. 2B
and C). Similar results were obtained using immunopuri¢ed
CC3 antibodies (data not shown).
On the basis of its homology to RCC1, we examined
whether HERC3 has GEF activity for Ran, GST-HERC3
and GST-HERC3 RLD (residues 1^392) fusion proteins
were used in a GEF assay in which we monitored [3H]GDP
release from [3H]GDP loaded Ran. As positive control, we
used the Ran-GEF RCC1 as a GST-RCC1 fusion protein.
As shown in Fig. 2D, neither HERC3 nor the HERC3
RLD promoted [3H]GDP dissociation from Ran in conditions
Fig. 3. Ubiquitin binding by HERC3 and HERC3 ubiquitination. A: Pull-down experiments with GST and GST-ubiquitin. Left panel: Compe-
tition assay. Wild-type HERC3 protein was synthesized in the rabbit reticulocyte system in the presence of [35S]methionine and incubated with
either GST (GST), GST-ubiquitin (GST-Ub), or GST-ubiquitin plus free ubiquitin (Ub). After binding to glutathione-Sepharose and extensive
washing, proteins were eluted from the beads with sample bu¡er containing DTT and resolved by discontinuous 7^12% PAGE/SDS in parallel
with rabbit reticulocyte lysate containing the transcribed and translated protein (right lane). After staining with Coomassie blue, gels were dried
and autoradiographed. Right panel: Radiolabeled wild-type HERC3 protein (Wt) and C1018A HERC3 protein (C-A) were synthesized as
above and incubated with either GST beads (GST) or GST-ubiquitin beads (GST-Ub). After extensive washing, proteins were eluted as above
and resolved by discontinuous 7^12% PAGE/SDS in parallel with aliquots of rabbit reticulocyte lysate containing the transcribed and translated
protein products. After staining with Coomassie blue, gels were dried and autoradiographed. Comparable amounts of GST and GST-ubiquitin
proteins were pulled-down as seen by Coomassie blue staining (bottom panels). Asterisk indicates slower migrating HERC3 bands. B: Ubiqui-
tin adduct formation of HERC3 and mutant HERC3 proteins. Left panel: Wild-type HERC3 protein (Wt), C1018A HERC3 protein (C-A)
and control luciferase (Luc) were synthesized as in A and incubated in the presence (+) or absence (3) of GST-ubiquitin (GST-Ub). Reactions
were stopped in sample bu¡er and proteins resolved by 7% PAGE/SDS. After ¢xation, gels were dried and autoradiographed. Right panel:
Competition assay. Radiolabeled wild-type HERC3 protein was incubated in the presence of GST (GST) GST-ubiquitin (GST-Ub) or GST-
ubiquitin plus free ubiquitin (Ub). Reactions were stopped as in A and proteins resolved by discontinuous 7^12% PAGE/SDS. After ¢xation,
gels were dried and autoradiographed. Asterisks indicate slower migrating HERC3 bands. C: HERC3 is ubiquitinated and degraded by the
proteasome in vivo. 100 mm plates of COS-1 cells were either transfected with 8 Wg of pcDNA3.1HisC (vector), expression plasmid pCC36
(wild-type HERC3, Wt) or pCC43 (C1018A HERC3 mutant, C-A). 24 h later, cells from each transfection were split into two 60 mm plates,
and treated overnight with DMSO (3) or the proteasome inhibitor LLnL at a concentration of 50 WM (+). Protein extracts (100 Wg) were re-
solved by 7% PAGE/SDS and immunoblotted with CC1 antibody (top panel), anti-M2-pyruvate kinase (M2-PK) antibody (middle panel) and
anti-K-tubulin antibody (bottom panel). D: Binding of GST-HERC3 produced in bacteria to a ubiquitin a⁄nity matrix. A control lysate (con-
trol) and a GST-HERC3-containing lysate (GST-HERC3) were incubated with either GST or GST-ubiquitin cross-linked to an agarose matrix.
After binding and extensive washing, aliquots were removed, eluted with sample bu¡er, resolved by 7% PAGE/SDS and immunoblotted with
CC1 antibody in parallel with aliquots of control and HERC3-containing lysates. Arrowheads show positions of the indicated proteins. Molec-
ular mass markers are expressed in kDa. IB, immunoblot.
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that allowed RCC1 to stimulate this release. The HERC3
colocalization with vesicular proteins, including GTPases
ARF and Rab5, raised the possibility that its substrate might
be one of these GTPases or other members of these two fam-
ilies of GTPases that control intracellular transport. In order
to check this point, we performed GEF assays with Rab pro-
teins (Rab3A, Rab5 and Rab8) and ARF proteins (ARF1 and
ARF6). We also tested members of the remaining two families
of small GTPases: H-Ras for Ras family and Rac and RhoA
for Rho family. As shown in Fig. 2E, HERC3 did not pro-
mote guanine nucleotide exchange on any of the small
GTPases assayed.
3.3. Ubiquitin binding and polyubiquitination
The presence of a HECT domain in HERC3 suggests that it
may bind ubiquitin. To check this possibility, we performed
pull-down experiments with GST-ubiquitin bound to gluta-
thione beads incubated with [35S]methionine-radiolabeled
HERC3 protein synthesized in the rabbit reticulocyte system.
Glutathione beads in the presence of GST-ubiquitin speci¢-
cally pulled down the wild-type form of HERC3 (Fig. 3A, left
panel, arrowhead). This binding probably did not occur
through a thioester bond because the same HERC3 mobility
was observed by running the samples under non-reducing
conditions (data not shown). As it was expected, the addition
of free ubiquitin avoided this interaction. A conserved cys-
teine residue in the HECT domain is essential for the ubiq-
uitin binding and ubiquitinating activity of HECT proteins
[7]. The equivalent cysteine in HERC3 is C1018. To analyze
the importance of C1018 in HERC3 binding to ubiquitin, we
generated a mutant form of HERC3 in which the residue was
altered to alanine (C1018A HERC3). Pull-down experiments
with 35S-labeled C1018A HERC3 protein showed that it could
also bind to GST-ubiquitin, but to a lesser extent (Fig. 3A,
right panel, arrowhead).
GST-ubiquitin pull-down experiments also speci¢cally re-
covered high molecular weight forms of wild-type and
C1018A HERC3 proteins (Fig. 3A, asterisk) that might cor-
respond to GST-ubiquitinated forms of these proteins. To
investigate whether GST-ubiquitin molecules may be attached
to HERC3, [35S]methionine-radiolabeled HERC3 proteins
were synthesized in the rabbit reticulocyte system and incu-
bated in the presence or absence of GST-ubiquitin. This in-
cubation resulted in the formation of HERC3 species of high-
er molecular weight when GST-ubiquitin was added (Fig. 3B,
right panel, asterisks). The size increase of these HERC3 spe-
cies is consistent with the attachment of multiple GST-ubiq-
uitin moieties (35 kDa) to HERC3 protein. These species were
DTT-resistant, indicating that this attachment involves iso-
peptidic bonds rather than thioester bonds. As it was ex-
pected, the addition of free ubiquitin avoided the formation
of HERC3 species of higher molecular weight. Interestingly,
similar results were obtained with the C1018A mutant (Fig.
3B, left panel). The higher molecular weight bands were not
observed in 35S-labeled luciferase, which was used as negative
control (Fig. 3B, left panel).
The HERC3 ubiquitination might target the protein to pro-
teasome-mediated degradation. To con¢rm this hypothesis,
we tested the e¡ect of the proteasome inhibitor LLnL on
HERC3 levels in vivo. As shown in Fig. 3C, the treatment
with LLnL of COS-1 cells transfected with HERC3 cDNA
resulted in an increase of HERC3 levels (Fig. 3C) and accu-
mulation of ubiquitinated forms of HERC3 after overexposi-
tion (data not shown). As expected, similar results were ob-
tained for C1018A mutant (Fig. 3C). Levels of K-tubulin and
M2-pyruvate kinase are shown as controls (Fig. 3C). These
results show that the HERC3 ubiquitination observed in vitro
is also produced in vivo and that it targets HERC3 for pro-
teasome degradation, thereby regulating the levels of HERC3
in the cell.
The HERC3 ubiquitination (Fig. 3B and C) and its inter-
action with ubiquitin (Fig. 3A) led us to think whether the
association of ubiquitin with HERC3 is signi¢cant beyond
normal substrate recognition by the ubiquitin/proteasome
pathway. To answer this question, we have analyzed whether
HERC3 can be a⁄nity puri¢ed from bacteria using a ubiqui-
tin matrix. To this end, we have cross-linked puri¢ed GST-
ubiquitin to an agarose matrix. A bacterial lysate of GST-
HERC3 fusion protein was incubated with the GST-ubiquitin
agarose. Under these conditions, GST-HERC3 protein was
speci¢cally puri¢ed (Fig. 3D). As negative controls of this
experiment, we have used a GST agarose matrix and bacterial
lysate not expressing GST-HERC3 (Fig. 3D).
4. Discussion
The structural features of the HERC proteins suggest that
they are involved in the regulation of intracellular transport,
cell cycle control and ubiquitin-dependent processes [1,10^13].
HERC3 protein is a previously unstudied member of this
family. Now, we report the identi¢cation of HERC3 protein.
This protein was found in all the cell types tested suggesting
that it is ubiquitous and con¢rming the expression previously
reported by Northern blot [13,14,17]. The subcellular distri-
bution of HERC3 between the cytosol and vesicular mem-
branes suggests that its association with vesicles might be
transient, a common trait of vesicular tra⁄c proteins [6].
Moreover, its colocalization with L-COP, ARF and Rab5
proteins suggests a possible role for HERC3 in intracellular
transport. The vesicular-type pattern observed by confocal
microscopy resembles that found for HERC1 except that
HERC3 was not found in the Golgi [10].
The presence of a conserved RLD indicates that HERC
proteins are putative guanine nucleotide exchange factors.
This also applies to the RLD-containing proteins that do
not belong to HERC family, some of which have been impli-
cated in human diseases: Retinitis Pigmentosa GTPase regu-
lator (RPGR), which is the protein product for the gene
whose mutation is the major cause of X-linked Retinitis Pig-
mentosa [18^20]; DelGEF, for deafness locus associated pu-
tative guanine nucleotide exchange factor [21] ; a protein as-
sociated with myc (Pam) [22] ; and CHC1L (chromosome
condensation-1 like), a protein with a potential role in tumors
and retinal disease [23]. Little is known about which GTPases
may be regulated by these putative GEFs which have a po-
tential role in human pathologies. The only information avail-
able is that HERC1 RLD1 can stimulate guanine nucleotide
dissociation for ARF1, Rab3A and Rab5. The homology be-
tween HERC1 and HERC3 and their subcellular location in
vesicular structures led us to analyze whether HERC3 can
stimulate guanine nucleotide exchange in various GTPases
of Ras superfamily (Ran, Ras, Rac, RhoA, Rab3A, Rab5,
Rab8, ARF1 and ARF6). HERC3 did not stimulate guanine
nucleotide dissociation on any of the GTPases tested. The
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colocalization between HERC3 and Rab5 and ARF proteins
also led us to check a possible association similar to that
described between RCC1 and Ran [24] or HERC1 and
ARF1 [10]. Although our attempts to ¢nd these protein^pro-
tein interactions using insect cells infected with recombinant
baculovirus expressing these proteins failed (data not shown),
we cannot rule out that HERC3 could act on some other
GTPase, yet to be identi¢ed.
HERC proteins are predicted to have E3 ligase activity. The
functionality of the isolated HECT domains has been reported
for HERC1 and HERC3, and their preference for di¡erent
E2s, UbcH5 and UbcH7, respectively [17]. Now, the experi-
ments with GST-ubiquitin show that full-length HERC3 pro-
tein is also able to bind ubiquitin (Fig. 3), which is compatible
with a function as an E3 ubiquitin ligase. Although the cys-
teine 1018 is not essential for this association, the fact that the
C1018A mutant binds less to GST-ubiquitin beads (Fig. 3A)
seems to indicate that the cysteine could stabilize the ubiquitin
binding.
GST-ubiquitin HERC3 adducts were insensitive to DTT
suggesting the ubiquitination of HERC3 on lysines. Data ob-
tained in vivo further support HERC3 ubiquitination by
showing the increase in the levels of HERC3 and appearance
of higher molecular weight forms of HERC3 after inhibition
of the proteasome in COS-1 cells (Fig. 3C and data not
shown). HECT proteins RSP5 and E6-AP display self-ubiq-
uitination activity. Reported data suggest an intramolecular
transfer of ubiquitin for RSP5 and an intermolecular transfer
for E6-AP [7,25,26]. HERC3 ubiquitination is unlikely to be
self-ubiquitination since mutant HERC3 is also ubiquitinated
and to the same extent (Fig. 3B, asterisk). HERC3 ubiquiti-
nation seems to indicate a ¢ne regulation of HERC3 levels
and supports the hypothesis that ubiquitination is common to
HECT proteins [25]. Moreover, the F-box component of SCF
ligases, another subclass of E3 ubiquitin protein ligases is also
regulated by ubiquitination [27].
Structural comparison between four members of the HECT
family groups them in two subfamilies : the large proteins
HERC1 and HERC2, which contain other domains in addi-
tion to RCC1 and HECT in their primary structure, and the
smaller proteins HERC3 and HERC4, which contain only the
RCC1 and HECT domains. Chromosomal location also
points out this relationship. Human HERC1 and HERC2
map closely in chromosome 15q and human HERC3 and
HERC4 in chromosome 4q. These proximal locations suggest
that genomic duplication led to each protein subfamily
[1,12,13,15,28]. These characteristics probably indicate similar
functions for each subclass. HERC4 interacts with several
cyclins and is regulated by tumor suppressor proteins p53
and retinoblastoma [13]. Whether HERC3 interacts with cy-
clins and whether its expression is regulated by tumor sup-
pressor proteins remains to be determined.
In summary, we identify HERC3 protein. Its subcellular
localization is compatible with a role in vesicular tra⁄cking
and its association with ubiquitin suggests that it may regulate
ubiquitin-dependent processes. Identi¢cation of HERC3 inter-
acting proteins may help us to better understand the function
of HERC3 in cellular processes.
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